Related Experiment Videos
Meeting highlights: adjuvant therapy for primary breast cancer
J H Glick1, R D Gelber, A Goldhirsch
1University of Pennsylvania Cancer Center, Philadelphia 19104.
Journal of the National Cancer Institute
|October 7, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Breast (Edinburgh, Scotland)·2022
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Immediate breast reconstruction with latissimus dorsi flap for patients with local recurrence of breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Anal cancer burden among people with HIV across US states, DC, and major metro areas.
Journal of the National Cancer Institute·2026
Benchmarking female breast cancer survival in africa, Central and South america, and asia (SURVCAN-3).
Journal of the National Cancer Institute·2026
Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.
Journal of the National Cancer Institute·2026
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
Journal of the National Cancer Institute·2026
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.
Journal of the National Cancer Institute·2026
Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.
Journal of the National Cancer Institute·2026